BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. ✅
Go to Publication ✅
International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 42 Issue 6 Pages: 475-81 Pub: 2013 Dec Epub: 2013 Sep 7 Authors Sikorska H , Smoragiewicz W , |
|
|
Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. ✅
Go to Publication ✅
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (Korean J Gastroenterol ) Vol: 65 Issue 4 Pages: 215-21 Pub: 2015 Apr Epub: Authors Shadnoush M , Hosseini RS , Khalilnezhad A , Navai L , Goudarzi H , Vaezjalali M , |
|
|
Molecular and microbiological analysis of caecal microbiota in rats fed with diets supplemented either with prebiotics or probiotics. ✅
International journal of food microbiology (Int J Food Microbiol ) Vol: 98 Issue 3 Pages: 281-9 Pub: 2005 Feb 15 Epub: Authors Montesi A , García-Albiach R , Pozuelo MJ , Pintado C , Goñi I , Rotger R , |
|
|
Molecular and microbiological analysis of caecal microbiota in rats fed with diets supplemented either with prebiotics or probiotics. ✅
International journal of food microbiology (Int J Food Microbiol ) Vol: 98 Issue 3 Pages: 281-9 Pub: 2005 Feb 15 Epub: Authors Montesi A , García-Albiach R , Pozuelo MJ , Pintado C , Goñi I , Rotger R , |
|
|
Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: Issue Pages: Pub: 2020 Nov 22 Epub: 2020 Nov 22 Authors Xu H , Ma C , Zhao F , Chen P , Liu Y , Sun Z , Cui L , Kwok LY , Zhang H , |
|
|
Bifidobacterium animalis subsp. lactis BB-12 Has Effect Against Obesity by Regulating Gut Microbiota in Two Phases in Human Microbiota-Associated Rats. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 811619 Pub: 2021 Epub: 2022 Jan 10 Authors Mao K , Gao J , Wang X , Li X , Geng S , Zhang T , Sadiq FA , Sang Y , |
|
|
Bifidobacterium animalis subsp. lactis HN019 has antimicrobial activity against endodontic pathogens in vitro. ✅
Go to Publication ✅
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: Issue Pages: Pub: 2023 Aug 26 Epub: 2023 Aug 26 Authors Araujo LDC , da Silva RAB , Silva CMPC , Salvador SLS , Messora MR , Furlaneto FAC , Mastrange MDA , Pucinelli CM , da Silva LAB , |
|
|
Differential pattern of indigenous microbiome responses to probiotic Bifidobacterium lactis V9 consumption across subjects. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 136 Issue Pages: 109496 Pub: 2020 Oct Epub: 2020 Jun 29 Authors Ma C , Huo D , You Z , Peng Q , Jiang S , Chang H , Zhang J , Zhang H , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
